Press Release and News Archives
- Baylor's CHASE program featured in a Houston Public Radio news story - January 14, 2008
- enGene raises $6.4 million in Series A funding - March 17, 2008
- ImmunoVac licenses an immunotherapy involving the suppression of negative immune regulators. - May 15, 2007
- Baylor and Advantagene have entered into an agreement for development of a novel cancer immunotherapy. - April 30, 2007
- LigoCyte Initiates Phase I Trial of Norovirus Vaccine. - April 3, 2007
- VGX licenses a broad range of Growth Hormone Releasing Hormone related intellectual property. - May 14, 2007
- Immusol announces license agreement with Baylor for a novel cancer therapy. - January 31, 2006
- TyRx Pharma announces an exclusive license agreement with Baylor and M. D. Anderson Cancer. Center - January 30, 2006
Better World Reports: How academic research contributs to society
- Agennix; developing therapies for cancer and wound healing - 2008 edition
- Opexa; developing individualized therapies for Multiple Sclerosis - 2008 edition